200,000+ products from a single source!
sales@angenechem.com
130800-90-7 | 4-Pyrimidinamine, 2-(4-methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)-
CAS No: 130800-90-7 Catalog No: AG000UYO MDL No:
Product Description
Catalog Number:
AG000UYO
Chemical Name:
4-Pyrimidinamine, 2-(4-methyl-1-piperazinyl)-5-(2,3,5-trichlorophenyl)-
CAS Number:
130800-90-7
Molecular Formula:
C15H16Cl3N5
Molecular Weight:
372.6800
IUPAC Name:
2-(4-methylpiperazin-1-yl)-5-(2,3,5-trichlorophenyl)pyrimidin-4-amine
InChI:
InChI=1S/C15H16Cl3N5/c1-22-2-4-23(5-3-22)15-20-8-11(14(19)21-15)10-6-9(16)7-12(17)13(10)18/h6-8H,2-5H2,1H3,(H2,19,20,21)
InChI Key:
PDOCBJADCWMDGL-UHFFFAOYSA-N
SMILES:
CN1CCN(CC1)c1ncc(c(n1)N)c1cc(Cl)cc(c1Cl)Cl
UNII:
OON9AVW1T3
Properties
Complexity:
393
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
371.047g/mol
Formal Charge:
0
Heavy Atom Count:
23
Hydrogen Bond Acceptor Count:
5
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
372.678g/mol
Monoisotopic Mass:
371.047g/mol
Rotatable Bond Count:
2
Topological Polar Surface Area:
58.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.6
Literature
| Title | Journal |
|---|---|
| Oxadiazolylindazole sodium channel modulators are neuroprotective toward hippocampal neurones. | Journal of medicinal chemistry 20090514 |
| Sipatrigine could have therapeutic potential for major depression and bipolar depression through antagonism of the two-pore-domain K+ channel TREK-1. | Medical hypotheses 20080101 |
| The neuroprotective agent sipatrigine blocks multiple cardiac ion channels and causes triangulation of the ventricular action potential. | Clinical and experimental pharmacology & physiology 20051201 |
| Actions of sipatrigine, 202W92 and lamotrigine on R-type and T-type Ca2+ channel currents. | European journal of pharmacology 20030425 |
| Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels. | Neuropharmacology 20030301 |
| Synthesis and structure-activity relationships of 6,7-benzomorphan derivatives as use-dependent sodium channel blockers for the treatment of stroke. | Journal of medicinal chemistry 20020815 |
| Lamotrigine derivatives and riluzole inhibit INa,P in cortical neurons. | Neuroreport 20020702 |
| Identification of a novel voltage-gated Na+ channel rNa(v)1.5a in the rat hippocampal progenitor stem cell line HiB5. | Pflugers Archiv : European journal of physiology 20011001 |
| Effects of extracellular pH on the interaction of sipatrigine and lamotrigine with high-voltage-activated (HVA) calcium channels in dissociated neurones of rat cortex. | Neuropharmacology 20010501 |
| The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K(+) channels TREK-1 and TRAAK. | Brain research 20010216 |
| Molecular determinants of voltage-dependent gating and binding of pore-blocking drugs in transmembrane segment IIIS6 of the Na(+) channel alpha subunit. | The Journal of biological chemistry 20010105 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.